80 related articles for article (PubMed ID: 2297705)
1. A Mr 43,000 epidermal growth factor-related protein purified from the urine of breast cancer patients.
Eckert K; Granetzny A; Fischer J; Nexø E; Grosse R
Cancer Res; 1990 Feb; 50(3):642-7. PubMed ID: 2297705
[TBL] [Abstract][Full Text] [Related]
2. Purification of a high molecular weight form of epidermal growth factor from urine of breast cancer patients.
Eckert K; Granetzny A; Fischer J; Grosse R
Biomed Biochim Acta; 1989; 48(1):111-20. PubMed ID: 2789043
[TBL] [Abstract][Full Text] [Related]
3. Human A673 cells secrete high molecular weight EGF-receptor binding growth factors that appear to be immunologically unrelated to EGF or TGF-alpha.
Stromberg K; Hudgins WR; Fryling CM; Hazarika P; Dedman JR; Pardue RL; Hargreaves WR; Orth DN
J Cell Biochem; 1986; 32(4):247-59. PubMed ID: 3492500
[TBL] [Abstract][Full Text] [Related]
4. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes.
Zarnegar R; Michalopoulos G
Cancer Res; 1989 Jun; 49(12):3314-20. PubMed ID: 2524251
[TBL] [Abstract][Full Text] [Related]
5. Variant forms of rat epidermal growth factor present in the urine of nude rats bearing human tumors.
Hudgins WR; Orth DN; Stromberg K
Cancer Res; 1988 Mar; 48(6):1428-34. PubMed ID: 3257897
[TBL] [Abstract][Full Text] [Related]
6. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA
Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653
[TBL] [Abstract][Full Text] [Related]
7. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
Stromberg K; Hudgins WR
Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
[TBL] [Abstract][Full Text] [Related]
8. Human brain tumor-associated urinary high molecular weight transforming growth factor: a high molecular weight form of epidermal growth factor.
Stromberg K; Hudgins WR; Dorman LS; Henderson LE; Sowder RC; Sherrell BJ; Mount CD; Orth DN
Cancer Res; 1987 Feb; 47(4):1190-6. PubMed ID: 3026622
[TBL] [Abstract][Full Text] [Related]
9. Multiplicity of transforming growth factors in human malignant effusions.
Seo MK; Lynch KE; Podolsky DK
Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
[TBL] [Abstract][Full Text] [Related]
10. High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer.
Sherwin SA; Twardzik DR; Bohn WH; Cockley KD; Todaro GJ
Cancer Res; 1983 Jan; 43(1):403-7. PubMed ID: 6600160
[TBL] [Abstract][Full Text] [Related]
11. Partial purification of transforming growth factors from human milk.
Zwiebel JA; Bano M; Nexo E; Salomon DS; Kidwell WR
Cancer Res; 1986 Feb; 46(2):933-9. PubMed ID: 3000589
[TBL] [Abstract][Full Text] [Related]
12. Relationship between 43 kDa epidermal growth factor-related clonogenic activity and clinical parameters for breast cancer.
Eckert K; Granetzny A; Fischer J; Grosse R
Anticancer Res; 1991; 11(6):2125-30. PubMed ID: 1776851
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of a novel transforming growth factor.
Halper J; Moses HL
Cancer Res; 1987 Sep; 47(17):4552-9. PubMed ID: 2887280
[TBL] [Abstract][Full Text] [Related]
14. Identification of epidermal growth factor as a component of the rat urinary bladder tumor-enhancing urinary fractions.
Yura Y; Hayashi O; Kelly M; Oyasu R
Cancer Res; 1989 Mar; 49(6):1548-53. PubMed ID: 2784351
[TBL] [Abstract][Full Text] [Related]
15. Sarcoma growth factor (SGF): specific binding to epidermal growth factor (EGF) membrane receptors.
De Larco JE; Todaro GJ
J Cell Physiol; 1980 Feb; 102(2):267-77. PubMed ID: 6246130
[TBL] [Abstract][Full Text] [Related]
16. Comparison of urinary transforming growth factor-alpha in women with disseminated breast cancer and healthy control women.
Stromberg K; Duffy M; Fritsch C; Hudgins WR; Sharp ES; Murphy LD; Lippman ME; Bates SE
Cancer Detect Prev; 1991; 15(4):277-83. PubMed ID: 1794134
[TBL] [Abstract][Full Text] [Related]
17. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
Ethier SP; Langton BC; Dilts CA
Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factors in the urine of normal, pregnant, and tumor-bearing humans.
Twardzik DR; Sherwin SA; Ranchalis J; Todaro GJ
J Natl Cancer Inst; 1982 Oct; 69(4):793-8. PubMed ID: 6288992
[TBL] [Abstract][Full Text] [Related]
19. Comparison of growth factors functionally related to epidermal growth factor in the urine of normal and human tumor-bearing athymic mice.
Twardzik DR; Kimball ES; Sherwin SA; Ranchalis JE; Todaro GJ
Cancer Res; 1985 May; 45(5):1934-9. PubMed ID: 3872712
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
